[Effect of ischemic preconditioning on myocardial bcl-2, bax, p53 gene expression during ischemia/reperfusion period in rabbits].

Hunan Yi Ke Da Xue Xue Bao

Department of Anesthesiology, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Published: April 2003

Objective: To investigate the effects of ischemic preconditioning on myocardial bcl-2, bax, p53 gene expression during ischemia/reperfusion period in rabbits.

Methods: Twenty four rabbits were randomly allocated to three groups (n = 8), pseudo-operation group(Group P), ischemia/reperfusion group (Group IR) and ischemic preconditioning group(Group IP). Group IR and Group IP were subjected to three hours of left anterior descending coronary artery occlusion followed for three hours of reperfusion. Ischemic preconditioning was achieved by three 5-minute cycles of ischemia, each followed by 5 minutes of reperfusion. Apoptosis index(AI) and protein expression of Bcl-2, Bax, and p53 in the border zone of myocardium of ischemic area at risk were obtained with a flow cytometry.

Results: Compared with Group IR, AI was significantly reduced in Group IP(P < 0.01). Bcl-2 expressions was higher in Group IP than in Group IR, while bax and p53 expressions were lower in Group IP than in Group IR.

Conclusion: The rabbit myocardial apoptosis induced by ischemic preconditioning inhibited ischemia-reperfusion in vivo partly related to the modulating of bcl-2, bax and p53 expression.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ischemic preconditioning
20
bax p53
20
bcl-2 bax
16
group group
16
group
10
preconditioning myocardial
8
myocardial bcl-2
8
p53 gene
8
gene expression
8
expression ischemia/reperfusion
8

Similar Publications

Purpose: Reperfusion of the ischaemic heart is essential to limit myocardial infarction. However, reperfusion can cause cardiomyocyte hypercontracture. Recently, cardiac myosin-targeted inhibitors (CMIs), such as Mavacamten (MYK-461) and Aficamten (CK-274), have been developed to treat patients with cardiac hypercontractility.

View Article and Find Full Text PDF

Background: Cholecystectomy often disrupts autonomic balance, impacting recovery. Remote ischemic preconditioning (RIPC) may enhance ANS function and protect organs, but its role in cholecystectomy is unclear.

Methods: In this randomized controlled trial, 80 patients aged 45 to 65 years, scheduled for elective laparoscopic cholecystectomy, were randomly assigned to either the RIPC group or the control group.

View Article and Find Full Text PDF

Remote ischemic preconditioning (RIPC) is reported to have early-phase and delayed-phase organ-protective effects. Previous studies have focused on the organ protection of a single RIPC protocol, and the clinical outcomes remain uncertain. Whether the modified RIPC (mRIPC) protocol performed repeatedly provides cardiopulmonary protection is still uncertain.

View Article and Find Full Text PDF

Urinary biomarker studies in cardiothoracic and kidney-sparing surgery have demonstrated renal protection by Remote Ischaemic PreConditioning (RIPC). RIPC intervention generates cycles of ischaemia and reperfusion of the limbs before the actual ischaemia of the target organ (e.g.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!